2型糖尿病患者微血管动脉粥样硬化改变的危险因素。

Risk factors for microvascular atherosclerotic changes in patients with type 2 diabetes mellitus.

作者信息

Simić Iveta, Pećin Ivan, Tedeschi-Reiner Eugenia, Zrinsćak Ozren, Sućur Nediljko, Reiner Zeljko

机构信息

University of Zagreb, University Hospital Center Zagreb, Department of Internal Medicine, Zagreb, Croatia.

出版信息

Coll Antropol. 2013 Sep;37(3):783-7.

DOI:
Abstract

Diabetes mellitus is a metabolic disorder primarily characterized by elevated blood glucose levels and by microvascular and macrovascular complications which increase the morbidity and mortality. The aim of this study was to assess whether in high risk patients with type 2 diabetes mellitus whose blood pressure and lipid levels are well controlled still exist risk factors for microvascular changes and target organ damage (nephropathy and retinopathy). In this case control retrospective study 326 patients (111 with nephropathy and/or retinopathy and 215 controls) were enrolled. Nephropathy or retinopathy was present in 10.1% and 26.9% cases, respectively. Only 71% of patients (no significant difference between cases and controls) were treated with antidiabetic drugs. Therefore their diabetes was not properly controlled (hemoglobin A1c was 7.96% in cases and 7.58% in controls). Patients with microvascular changes had significantly longer diabetes than the controls (p < 0.05) but there were no significant differences between these two groups concerning lipids concentrations. Statins and fibrates were used by significantly less (p < 0.05) patients with microvascular complications than by those without them (21.6% vs. 36.3% and 1.8% vs. 17.2% respectively). The results of this study suggest that the duration of the disease and adequate control of glycaemia in patients with type 2 diabetes mellitus are more important for microvascular complications than the serum lipoproteins levels. Lipid-lowering treatment might have an impact on microvascular complications in patients with type 2 diabetes, irrespectively of their serum lipid levels.

摘要

糖尿病是一种代谢紊乱疾病,主要特征为血糖水平升高以及微血管和大血管并发症,这些并发症会增加发病率和死亡率。本研究的目的是评估在血压和血脂水平得到良好控制的2型糖尿病高危患者中,是否仍存在微血管变化和靶器官损害(肾病和视网膜病变)的危险因素。在这项病例对照回顾性研究中,纳入了326例患者(111例患有肾病和/或视网膜病变,215例为对照)。肾病或视网膜病变分别出现在10.1%和26.9%的病例中。只有71%的患者(病例组和对照组之间无显著差异)接受了抗糖尿病药物治疗。因此,他们的糖尿病未得到妥善控制(病例组糖化血红蛋白为7.96%,对照组为7.58%)。有微血管变化的患者患糖尿病的时间明显长于对照组(p<0.05),但两组在血脂浓度方面无显著差异。与没有微血管并发症的患者相比,有微血管并发症的患者使用他汀类药物和贝特类药物的比例明显更低(p<0.05)(分别为21.6%对36.3%和1.8%对17.2%)。本研究结果表明,对于2型糖尿病患者的微血管并发症而言,疾病持续时间和血糖的充分控制比血清脂蛋白水平更为重要。降脂治疗可能会对2型糖尿病患者的微血管并发症产生影响,无论其血清血脂水平如何。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索